Table 3: Outcome of therapy with long acting TU in a population of men with type 2 diabetes and hypogonadism (BLAST) Hackett et al. IJCP Dec 2013 [38].

HbA1c
(%)
>7.5
Weight
(kg)
BMI
(kg/m2)
WC
(cm)
TC
(mmol/L)
EF
(TT < 8 nmol/L)
AMS
(points)
HADS-D GEQ
(% imp)

30 weeks −0.41 −0.7 −0.3 −2.5 −0.25 +3.0 −5.3 −1.01 46
value 0.007 0.13 0.01 0.012 0.025 0.006 0.095 0.64 <0.001
82 weeks −0.89 −2.7 −1.00 −4.2 −0.19 +4.31
+9.57
PDE5I
−8.1 −2.18 67–70
value 0.009 0.016 0.019 <0.001 0.035 0.003 0.001 0.001 0.0001